Regardless of the specific biological mechanism, these findings highlight the potential of improving NREM sleep as a therapeutic strategy to mitigate the accumulation and spread of pathological amyloid and tau, emphasizing its protective role in slowing the progression of AD. The gene discussed is MAPT; the disease is Alzheimer disease.